将BD Phoenix和磁盘扩散与汁微稀释进行比较,以确定耐卡巴耐药肠道细菌中塞费皮姆的敏感性
Aliaa Fouad1, Patricia J Simner2, David P Nicolau1,3
1Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
Journal of clinical microbiology
|May 7, 2024
概括
与参考方法相比,对抗卡巴胺耐药肠道细菌 (CRE) 测试cefepime易感性的测试显示BD和磁盘扩散的准确性较低,特别是对于产生卡巴酶的菌株. 这影响了对CRE感染的准确临床决定.
科学领域:
- 临床微生物学 临床微生物学
- 抗微生物耐药性 抗微生物耐药性
- 传染性疾病 传染性疾病
背景情况:
- 越来越多的报道显示,对卡巴胺耐药的肠道细菌 (CRE) 被测试为易受塞菲皮姆的细菌,这给诊断带来了挑战.
- 准确的敏感性测试对于指导CRE感染的有效治疗至关重要.
研究的目的:
- 为了比较BD Phoenix和磁盘扩散 (DD) 与参考微稀释 (BMD) 的cefepime测试性能.
- 为了评估carbapenemase生产 (CP-KPC-CRE) 和非生产 (非CP CRE) 隔离物的性能.
主要方法:
- 使用BD Phoenix和磁盘扩散 (DD) 进行了Cefepime敏感性测试.
- 结果与64个CP-KPC-CRE和58个非CP CRE分离物的参考微稀释 (BMD) 相比.
- 基本协议 (EA),分类协议 (CA) 和错误率 (ME,VME,MIE) 根据CLSI指南进行计算.
主要成果:
- 对于CP-KPC-CRE,BD Phoenix显示EA和CA<90%,但对于非CP CRE,EA为96.6%和CA为79.3%.
- 磁盘扩散 (DD) 对于CP-KPC-CRE和非CP CRE都有<90%的CA.
- 这两种方法都显示出>10%的轻微错误 (miEs) 和较高的MICs与BMD相比,特别是CP-KPC-CRE.
结论:
- 在CRE中,BD Phoenix和磁盘扩散在Cefepime敏感性测试中表现不佳,特别是产生卡巴酶的菌株.
- 观察到的差异,包括轻微的错误和较高的MIC,可能导致易感性错误分类,影响治疗策略.
- 需要进一步优化自动化系统和磁盘扩散方法,以可靠地检测对CRE的cefepime活性.
更多相关视频
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
33.0K
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
29.0K
相关概念视频
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
